NasdaqGS:CYTKBiotechs
Is Cytokinetics (CYTK) Still Cheap After Its Strong Share Price Run?
Cytokinetics (CYTK) has been drawing attention after recent share price moves, with the stock closing at $82.19 and showing double digit total returns over the past year and past 3 years.
See our latest analysis for Cytokinetics.
The recent 1-day share price return of 1.72% and 7-day share price return of 4.33% sit within a stronger trend, with a 30-day share price return of 7.07% and a 1-year total shareholder return of 147.86%, pointing to momentum that has been building rather than...